Adiponectin and cardiovascular remodeling in end-stage renal disease and co-morbid diabetes mellitus

被引:15
作者
Karakitsos, Dimitrios
De Groot, Eric
Patrianakos, Alexandros P.
Parthenakis, Frangiscos
Boletis, John
Karabinis, Andreas
Kyriazis, John
Vardas, Panos
Daphnis, Eugene
机构
[1] Heraklion Univ Hosp, Dept Nephrol, GR-71110 Iraklion, Crete, Greece
[2] Heraklion Univ Hosp, Dept Cardiol, GR-71110 Iraklion, Crete, Greece
[3] Gen State Hosp, Intens Care Unit, Athens, Greece
[4] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[5] Laiko Univ Hosp, Renal Transplantat Unit, Athens, Greece
[6] Gen Hosp Chios, Dialysis Unit, Chios, Greece
关键词
end-stage renal disease; diabetes mellitus; adiponectin; cardiovascular remodeling;
D O I
10.1159/000094403
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives and Methods: Altered plasma high-sensitivity C-reactive protein (hs-CRP) and adiponectin (ADP) may contribute to increased vascular inflammation and accelerated atherosclerosis in patients with end-stage renal disease (ESRD) and co-morbid diabetes. Common carotid artery intima-media thickness (CCA-IMT) and atherosclerotic plaque occurrence, left-ventricular mass index (LVMI), and pulse wave velocity of the proximal aorta (PWVr) were determined by ultrasound imaging in 120 ESRD (55 diabetic) patients, and 83 age-, sex-, and blood pressure-matched controls. Also, plasma levels of ADP and hs-CRP were determined and their relationships with the above cardiovascular alterations were analyzed. Results: LVMI, PWVr, CCA-IMT and atherosclerotic plaque occurrence were all increased in ESRD patients compared to controls (all p < 0.001). LVMl (p < 0.05), PWVr (p < 0.001), CCA-IMT (p < 0.001) and atherosclerotic plaque occurrence (p < 0.001) were increased in diabetic compared to nondiabetic ESRD patients. Hs-CRP levels were increased and ADP levels were decreased in diabetic compared to nondiabetic ESRD patients (both p < 0.001). ADP levels correlated inversely with hs-CRP (r=-0.473, p < 0.0001) in ESRD patients. Hs-CRP was positively correlated with LVMI (r = 0.365, p < 0.0001), PWVr (r = 0.42, p < 0.0001) and CCA-IMT (r = 0.18, p, = 0.047) while ADP inversely correlated with PWVr (r = -0.263, p = 0.0035) and CCA-IMT (r = -0.207, p = 0.022) in ESRD patients. Conclusion: The present results indicate diabetic disease-specific alterations in the biochemical parameters of hs-CRP and ADP in ESRD patients. The above biochemical parameters were intimately linked to the cardiovascular measurements of LVMI, PWVr and CCA-IMT in patients with ESRD and co-morbid diabetes mellitus. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:340 / 347
页数:8
相关论文
共 50 条
  • [31] Role of homocysteine in end-stage renal disease
    Wu, Chia-Chao
    Zheng, Cai-Mei
    Lin, Yuh-Feng
    Lo, Lan
    Liao, Min-Tser
    Lu, Kuo-Cheng
    CLINICAL BIOCHEMISTRY, 2012, 45 (16-17) : 1286 - 1294
  • [32] Impact of Diabetes Mellitus on Survival in Patients with End-Stage Renal Disease: A Three-Year Follow-Up
    Tomaszuk-Kazberuk, Anna
    Bachorzewska-Gajewska, Hanna
    Malyszko, Jolanta
    Malyszko, Jacek
    Mysliwiec, Michal
    Musial, Wlodzimierz J.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2011, 34 (02) : 83 - 86
  • [33] The effect of diabetes mellitus and end-stage renal disease on the number of CD34+ cells in the blood
    Cigdem Pala
    Ilker Altun
    Yavuz Koker
    Fatih Kurnaz
    Serdar Sivgin
    Ismail Koçyiğit
    Fatih Tanrıverdi
    Leylagul Kaynar
    Ferhan Elmali
    Mustafa Cetin
    Bülent Eser
    Annals of Hematology, 2013, 92 : 1189 - 1194
  • [34] The effect of diabetes mellitus and end-stage renal disease on the number of CD34+ cells in the blood
    Pala, Cigdem
    Altun, Ilker
    Koker, Yavuz
    Kurnaz, Fatih
    Sivgin, Serdar
    Kocyigit, Ismail
    Tanriverdi, Fatih
    Kaynar, Leylagul
    Elmali, Ferhan
    Cetin, Mustafa
    Eser, Bulent
    ANNALS OF HEMATOLOGY, 2013, 92 (09) : 1189 - 1194
  • [35] Effects of DPP-4 inhibitors on cardiovascular outcomes in patients with type 2 diabetes and end-stage renal disease
    Chan, Shang-Yih
    Ou, Shuo-Ming
    Chen, Yung-Tai
    Shih, Chia-Jen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 218 : 170 - 175
  • [36] Dialysis care, cardiovascular disease, and costs in end-stage renal disease in Brazil
    Sesso, Ricardo
    da Silva, Camilla Barbosa
    Kowalski, Sergio C.
    Manfredi, Silvia R.
    Canziani, Maria E.
    Draibe, Sergio A.
    Elgazzar, Heba A.
    Ferraz, Marcos B.
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2007, 23 (01) : 126 - 130
  • [37] The evaluation of underlyin cardiovascular disease among patients with end-stage renal disease
    Hedayati, SS
    Szczech, LA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (03) : 246 - 253
  • [38] Microbiota analysis in individuals with type two diabetes mellitus and end-stage renal disease: A pilot study
    Trandafir, Maria
    Pircalabioru, Gratiela Gradisteanu
    Savu, Octavian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2024, 27 (05)
  • [39] Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease
    Zoccali, C
    Mallamaci, F
    Tripepi, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 : 67 - 72
  • [40] Opportunities for improvement in the cardiovascular care of patients with end-stage renal disease
    McCullough, PA
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2004, 11 (03) : 294 - 303